Reuters Shares of drugmaker Mylan are sinking after a report from Bloomberg found that the company’s landmark anti-allergy device is in short-supply. The supply of Mylan’s EpiPen has been falling since May 2018, according to the Food and Drug Administration. Parents and pharmacists are doing all they can to get ahold EpiPens, while patients are […]
Mylan tumbles on reported shortages of its life-saving EpiPens (MYL)
Reuters Shares of drugmaker Mylan are sinking after a report from Bloomberg found that the company’s landmark anti-allergy device is in short-supply. The supply of Mylan’s EpiPen has been falling since May 2018, according to the Food and Drug Administration. Parents and pharmacists are doing all they can to get ahold EpiPens, while patients are […]